A phase I dose-finding study of vorinostat (V) combined with capecitabine (X) and cisplatin (P) as first-line therapy in patients with advanced gastric cancer

被引：0
|
作者：
Yoo, Changhoon [1 ]
Ryu, Min-Hee [1 ]
Ryoo, Baek-Yeol [1 ]
Koo, Dong Hoe [1 ]
Park, Inkeun [1 ]
Kang, Yoon-Koo [1 ]
机构：
[1] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.73
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer
    S. H. Waters
    A. Gillibrand
    H. Berry
    S. Kumar
    G. Velikova
    D. J. Dodwell
    Timothy J. Perren
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 407 - 412
  • [22] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Kang, Yoon-Koo
    Ryu, Min-Hee
    Yoo, Changhoon
    Chang, Heung-Moon
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Tae Won
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1435 - 1443
  • [23] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Yoon-Koo Kang
    Min-Hee Ryu
    Changhoon Yoo
    Heung-Moon Chang
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Tae Won Kim
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1435 - 1443
  • [24] Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
    Kim, TW
    Kang, YK
    Ahn, JH
    Chang, HM
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1893 - 1898
  • [25] Phase I dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unresectable locally advanced or metastatic gastric cancer
    Chi, Yihebali
    Yang, Jianliang
    Yang, Sheng
    Sun, Yongkun
    Jia, Bo
    Shi, Yuankai
    CHINESE JOURNAL OF CANCER RESEARCH, 2015, 27 (03) : 239 - 246
  • [26] Capecitabine (X) combined with fractionated cisplatin (C) as first-line therapy in Chinese patients (pts) with advanced gastric carcinoma (AGC).
    Jin, M
    Shen, L
    Hu, B
    Yu, J
    Wen, Z
    Su, Y
    Wang, B
    Chen, L
    Ying, H
    Chen, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 321S - 321S
  • [27] Postoperative chemoradiotherapy in gastric cancer - a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy
    Jansen, E. P. M.
    Boot, H.
    Dubbelman, R.
    Bartelink, H.
    Cats, A.
    Verheij, M.
    BRITISH JOURNAL OF CANCER, 2007, 97 (06) : 712 - 716
  • [28] Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy
    E P M Jansen
    H Boot
    R Dubbelman
    H Bartelink
    A Cats
    M Verheij
    British Journal of Cancer, 2007, 97 : 712 - 716
  • [29] Phase I study of docetaxel, oxaliplatin, and capecitabine as first-line therapy to patients with advanced gastroesophageal cancer
    Schonnemann, K. R.
    Andersen, M.
    Yilmaz, M.
    Jensen, H. A.
    Vestermark, L. W.
    Pfeiffer, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer
    Pagani, O
    Sessa, C
    Martinelli, G
    Crivellari, D
    Buonadonna, A
    Thürlimann, B
    Hess, D
    Borner, M
    Bauer, J
    Zampino, G
    Zimatore, M
    Graffeo, R
    Riva, A
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1999, 10 (05) : 539 - 545
12345